In addition, the efficacy estimate may be subject to bias due to the high rate of treatment discontinuation, and incomplete re-consent for longer term follow-up. In conclusion, there are doubts whether clinical efficacy has been demonstrated.
In addition, the efficacy estimate may be subject to bias due to the high rate of treatment discontinuation, and incomplete re-consent for longer term follow-up. In conclusion, there are doubts whether clinical efficacy has been demonstrated.